A carregar...

B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial

INTRODUCTION: An over-expression of CD19 has been shown in B cells of systemic sclerosis (SSc) and B cells are thought to contribute to the induction of skin fibrosis in the tight skin mouse model. The aim was to define the outcome on safety and the change in skin score after rituximab therapy in SS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bosello, Silvia, De Santis, Maria, Lama, Gina, Spanò, Cristina, Angelucci, Cristiana, Tolusso, Barbara, Sica, Gigliola, Ferraccioli, Gianfranco
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2888203/
https://ncbi.nlm.nih.gov/pubmed/20338043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar2965
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!